Dexmedetomidine Alleviates Ischemia/Reperfusion-Associated Acute Kidney Injury by Enhancing Autophagic Activity via the α2-AR/AMPK/mTOR Pathway
Frontiers in Bioscience-Landmark · 2023
DOI: 10.31083/j.fbl2812323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2023. Verfasst von Bi-Ying Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medi…. Hauptthemen laut MEDLINE: Dexmedetomidine, Acute Kidney Injury, Reperfusion Injury. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, The research project of Gusu School, Nanjing Medical University.
Abstract (Originalsprache)
Background
Dexmedetomidine (DEX) reportedly protects against ischemia-reperfusion (I/R) injury and associated damage to the kidneys, but the underlying mechanisms have yet to be established.
Methods
Unilateral nephrectomy was performed in Wistar rats, and the remaining kidney was clamped for 1 h prior to reperfusion to establish an experimental model system. These animals were then randomized into Sham, DEX + Sham, DEX + I/R, ATI (Altepamizole, α2-adrenergic receptor inhibitor) + DEX + I/R, and 3-MA (3-methyladenine, autophagy inhibitor) + DEX + I/R groups. Serum renal function biomarkers, acute kidney injury (AKI) histopathological scores, serum inflammatory factors, redox biomarkers, markers of autophagic flux, and autophagosome numbers were assessed. Levels of proteins related to the autophagic pathway, including mTOR and AMPK, were also analyzed.
Results
Serum creatinine and urea nitrogen levels in the I/R group were significantly elevated over those in sham control rats, as were AKI scores, serum inflammatory cytokine concentrations (IL-6, IL-1β, and TNF-α), and serum levels of the oxidative stress biomarker malondialdehyde (MDA). All of these parameters were significantly reduced in the DEX + I/R group relative to I/R model rats. I/R group rats also exhibited significant decreases in renal levels of autophagic flux-related biomarkers and autophagosome numbers relative to sham controls, while DEX administration partially restored normal autophagic flux in these rats. Acute I/R also suppress the expression of AMPK in the kidney while increasing mTOR expression, and DEX reversed these effects. The beneficial impact of DEX on I/R-associated AKI was ablated by ATI or 3-MA administration.
Conclusions
These analyses provide strong evidence for the ability of DEX to protect against I/R-associated AKI via the α2-AR/AMPK/mTOR pathway-mediated enhancement of autophagic activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Unit, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, 215008 Suzhou, Jiangsu, China.
- Suzhou Clinical Medical Center of Critical Care Medicine, 215001 Suzhou, Jiangsu, China.
- Department of Nephrology, The First Affiliated Hospital of Soochow University, 215006 Suzhou, Jiangsu, China.
- Department of Physiology and Neurosciences, Medical College of Soochow University, 215123 Suzhou, Jiangsu, China.
Förderung
- National Natural Science Foundation of China
- The research project of Gusu School, Nanjing Medical University
Zitieren
APA
Zhou, B. Y., Yang, J., Luo, R. R., Sun, Y. L., Zhang, H. T., Yang, A. X., & Zhang, G. X. (2023). Dexmedetomidine Alleviates Ischemia/Reperfusion-Associated Acute Kidney Injury by Enhancing Autophagic Activity via the α2-AR/AMPK/mTOR Pathway. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2812323
Vancouver
Zhou BY, Yang J, Luo RR, Sun YL, Zhang HT, Yang AX, et al. Dexmedetomidine Alleviates Ischemia/Reperfusion-Associated Acute Kidney Injury by Enhancing Autophagic Activity via the α2-AR/AMPK/mTOR Pathway. Frontiers in Bioscience-Landmark. 2023. doi:10.31083/j.fbl2812323
BibTeX
@article{Zhou2023,
author = {Zhou, Bi-Ying and Yang, Jing and Luo, Rui-Rui and Sun, Yan-Lin and Zhang, Hao-Tian and Yang, Ai-Xiang and Zhang, Guo-Xing},
title = {Dexmedetomidine Alleviates Ischemia/Reperfusion-Associated Acute Kidney Injury by Enhancing Autophagic Activity via the α2-AR/AMPK/mTOR Pathway},
journal = {Frontiers in Bioscience-Landmark},
year = {2023},
doi = {10.31083/j.fbl2812323}
}
EUVIMED